Plain-English translation of NCT07064473 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called combined with (a diabetes medication you may already be taking) to see if it can reduce the risk of heart-related events in people with type 2 diabetes, high blood pressure, and existing cardiovascular disease. About half of participants will receive the actual medication, and the other half will receive a placebo (a pill that looks identical but contains no active medicine). Everyone continues taking their regular medications for diabetes, blood pressure, and heart disease.
People with type 2 diabetes and heart disease face high risk of serious cardiovascular events like heart attacks and strokes. Researchers believe this medication may offer extra heart protection beyond what existing treatments provide, and this trial will help determine if that's true.
You likely qualify if…
You likely don't qualify if…
You will take one tablet by mouth once daily for up to 4 years and 3 months, continuing all your regular diabetes, blood pressure, and heart medications as usual. You will visit the study site regularly for check-ups, where doctors will take blood samples, record any heart-related events you experience, and monitor you for any side effects. The study involves frequent visits at the beginning and then regular monitoring throughout your participation to track your health.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
United States